Latest Articles and Analysis

Explores technology innovations in HIV care including mobile apps and drone pharmacy delivery.

UNAIDS report highlights HIV-HCV coinfection rates among people who inject drugs globally and in the US.

Reviews Biden's first 100 days on healthcare: infrastructure, subsidies, harm reduction, and health equity.

Analysis of Kanawha County HIV outbreak highlighting substance use, rural healthcare gaps, and pandemic impact.

Housing instability increases HIV/HCV acquisition by 55-65%; housing investments outpace health interventions.

COVID-19 vaccination priority for people with HIV and chronic liver disease amid immunological risks.

Merck-Gilead partnership on long-acting injectables Islatravir and Lenacapavir for HIV treatment.

Assesses pandemic's ongoing impact on HIV, HCV, and SUD surveillance and care with vaccine rollout.

COVID-19 vaccine development spurs reflection on 35-year HIV vaccine search and mRNA technology advances.

Arizona's restrictive Medicaid formulary limits single-tablet HIV regimens and HCV agents post-expansion.

Family courts and child welfare systems miss opportunities to address health needs and social determinants.

FDA approves Cabenuva, first long-acting injectable HIV regimen offering monthly alternative to daily pills.

HHS releases integrated Viral Hepatitis National Strategic Plan calling for a syndemic approach with HIV and STI.

Final rule allowing drug importation from Canada poses safety risks from counterfeit medications.

Evaluates pandemic's impacts on HIV, HCV, and SUD services including testing disruptions and telehealth expansion.